Document is current
Any future updates will be listed below
-
Authors
Thinyakul, Chanida https://orcid.org/0000-0002-2927-0595
Sakamoto, Yasuhisa
Shimoda, Mayuko https://orcid.org/0009-0009-6681-502X
Liu, Yanliang
Thongchot, Suyanee
Reda, Omnia https://orcid.org/0000-0002-1260-0527
Nita, Akihiro
Sakamula, Romgase https://orcid.org/0009-0006-9666-0709
Sampattavanich, Somponnat https://orcid.org/0000-0001-7783-6103
Maeda, Ayato
Chunthaboon, Paweenapon https://orcid.org/0009-0005-6614-030X
Nduru, David
Niimura, Mayumi
Kanamori, Yohei
Thuwajit, Peti
Nakayama, Keiichi I.
Guan, Kun-Liang https://orcid.org/0000-0003-1892-0174
Satou, Yorifumi https://orcid.org/0000-0002-1495-7810
Thuwajit, Chanitra https://orcid.org/0000-0001-9506-6405
Moroishi, Toshiro https://orcid.org/0000-0001-6419-3882
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP22gm6210030)
MEXT | Japan Science and Technology Agency (JPMJFR226J)
MEXT | Japan Society for the Promotion of Science (22H05635, 24H00864, and 24H00865)
Takeda Science Foundation
Kobayashi Foundation for Cancer Research
Kumamoto University
Mahidol University
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 10 October 2024
First Online: 17 October 2024
Competing interests
: The authors declare the following competing interests: K.-L.G. is a co-founder of and holds an equity interest in Vivace Therapeutics. T.M. is an Editorial Board Member for Communications Biology, but was not involved in the editorial review of, nor the decision to publish this article. All other authors declare no competing interests.
